|
|
|
Volumn 24, Issue 3 SUPPL. 8, 1997, Pages
|
|
Phase II trial of gemcitabine plus cisplatin in non-small cell lung cancer: A Hoosier Oncology Group Study
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CISPLATIN;
GEMCITABINE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
RIBONUCLEOTIDE REDUCTASE;
ADULT;
ADVANCED CANCER;
AGED;
CANCER INHIBITION;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DNA DETERMINATION;
DNA SYNTHESIS;
DOSE RESPONSE;
FEMALE;
GRANULOCYTOPENIA;
GROWTH INHIBITION;
HUMAN;
LUNG NON SMALL CELL CANCER;
MALE;
PATIENT CARE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TUMOR CELL LINE;
AGRANULOCYTOSIS;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
LUNG TUMOR;
MIDDLE AGED;
TREATMENT OUTCOME;
ADULT;
AGED;
AGRANULOCYTOSIS;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DEOXYCYTIDINE;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
RIBONUCLEOTIDE REDUCTASES;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
|
EID: 0030925123
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (36)
|
|
References (17)
|
